Evaluation of Levothyroxine Replacement Therapy After Total Thyroidectomy Using a Smart Wristband
- Sponsor
- Yeditepe University Hospital
- Study ID
- NCT07733375
- Status
- Recruiting
Conditions
- Hyperthyroidism
- Hypothyroidism
- Total Thyroidectomy
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Xiomi Smart Band 10 — DEVICEParticipants will wear a smart wristband continuously during the first postoperative month following total thyroidectomy. The device will passively record nighttime heart rate and heart rhythm data without affecting routine clinical care. The collected physiological data will be compared with thyroid function test results obtained 1 month after surgery to evaluate whether wearable-derived measurements can identify under- or over-replacement with levothyroxine before routine biochemical assessment.
Study Details
The goal of this observational study is to determine whether nighttime heart rate and heart rhythm data collected by a smart wristband can identify under- or over-replacement with levothyroxine before the routine 1-month thyroid function tests in adults who have undergone total thyroidectomy. After total thyroidectomy, patients usually start levothyroxine replacement therapy, and the dose is adjusted about 1 month later based on thyroid function tests. This study aims to determine whether changes in nighttime heart rate and heart rhythm can provide an earlier indication that the levothyroxine dose is too low or too high. The main questions it aims to answer are: Can nighttime heart rate and heart rhythm measured by a smart wristband identify under- or over-replacement with levothyroxine before routine thyroid function testing? How well do smart wristband measurements agree with thyroid function test results? Participants will: Wear a smart wristband after total thyroidectomy. Continue taking levothyroxine as prescribed by their physician. Undergo routine thyroid function testing approximately 1 month after surgery as part of standard clinical care. Allow researchers to compare smart wristband measurements with thyroid function test results to evaluate whether wearable data can provide an earlier indication of inadequate or excessive levothyroxine replacement.
Key Dates
- First listed
- Jul 29, 2026
- Start date
- Jul 22, 2026
- Status verified
- Jul 2026
- Primary completion
- Dec 31, 2026
- Completion
- Feb 1, 2027
Study Design
- Enrollment
- 40 participants (estimated)
Arms
- Arm: Total Thyroidectomy Patients Receiving LevothyroxineAdults undergoing total thyroidectomy who receive standard postoperative levothyroxine replacement therapy. Participants will wear a smart wristband during the early postoperative period to continuously record nighttime heart rate and heart rhythm. They will undergo routine thyroid function testing, including serum thyroid-stimulating hormone (TSH) and free thyroxine (fT4), 1 month after surgery as part of standard clinical care. Smart wristband-derived physiological data will be compared with thyroid function test results to evaluate whether wearable monitoring can identify under- or over-replacement with levothyroxine before the routine 1-month biochemical assessment.
Primary Outcome Measure
Diagnostic Performance of Smart Wristband-Derived Nighttime Heart Rate and Heart Rhythm for Detecting Inadequate Levothyroxine Replacement [ Time Frame: 1 month after total thyroidectomy ]
Central Contacts
- Banu Erkal, MD+905319867061
- Mustafa Erhan Ayşan, Professor+905322034879
Related Studies
- Natural History of Thyroid Function DisordersRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis PatientsRecruiting · University of California, Irvine · Orange, California
- Dosing of LT4 in Older IndividualsPHASE4 · Recruiting · University of Pennsylvania · Philadelphia, Pennsylvania
- A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult ParticipantsPHASE2/PHASE3 · Recruiting · AbbVie · Birmingham, Alabama